Hematology NewsArmored CAR protects T cells, induces remissionsJanuary 4, 2019Cellular TherapyImmuno-oncologyLymphoma & Plasma Cell DisordersCLLAggressive LymphomasImmunotherapyB Cell Lymphoma
Hematology NewsLong-term side effects of CAR T cells mostly mildJanuary 4, 2019Cellular TherapyCLLAggressive LymphomasImmunotherapyB Cell Lymphoma
Hematology NewsIbrutinib-rituximab ‘new standard of care’ in younger CLL patientsDecember 11, 2018CLLLeukemia, Myelodysplasia, TransplantationAggressive Lymphomas
Hematology News2018: A banner year for hematology drug approvalsDecember 5, 2018Business of MedicineCLLAggressive LymphomasMixed TopicsPractice ManagementLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsCLL resistance mechanism to venetoclax identifiedDecember 5, 2018CLLAggressive LymphomasLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsIbrutinib outperforms bendamustine and rituximab in older CLL patientsDecember 2, 2018CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsCortactin expression aids in CLL-MCL differentialNovember 28, 2018CLLMantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsASH 2018 coming attractions look at the big pictureNovember 21, 2018Aggressive LymphomasMultiple MyelomaCLLAnemiaMixed TopicsB Cell Lymphoma
Hematology NewsConsider treatment, testing when CLL symptoms emergeNovember 13, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent Lymphoma
Hematology NewsCLL: The initial work-upNovember 13, 2018CLLIndolent LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsVariant not linked to CLL in Southeast EuropeNovember 7, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsSandoz halts pursuit of U.S. approval for rituximab biosimilarNovember 5, 2018CLLLymphoma & Plasma Cell DisordersIndolent LymphomaFollicular LymphomaB Cell Lymphoma
Hematology NewsIbrutinib discontinuation harms survival in CLLOctober 18, 2018CLLMantle Cell LymphomaIndolent LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsIbrutinib plus obinutuzumab gets priority review in CLL/SLLOctober 17, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, TransplantationImmuno-oncology
